Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Gemini establishes drug target discovery collaboration with CuraGen

April 6, 2000

No Comments

Array BioPharma and Lilly form drug discovery collaboration

April 5, 2000

No Comments

Medarex and Raven Biotechnologies form antibody development collaboration

April 4, 2000

No Comments

Meperidine analogues under study as dopamine uptake inhibitors by NIDA and collaborators

March 31, 2000

No Comments

RHeoGene updates gene-switching development program at BIO 2000

March 31, 2000

No Comments

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

March 30, 2000

No Comments

ICAgen and Yamanouchi to develop novel CNS therapeutics

March 30, 2000

No Comments

Genzyme Transgenics expands agreement with Centocor for second monoclonal antibody

March 27, 2000

No Comments

Dyax and Human Genome Sciences enter drug discovery agreement

March 27, 2000

No Comments

Millennium extends inflammation and autoimmune alliance with Kyowa Hakko

March 24, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Gemini establishes drug target discovery collaboration with CuraGen

Array BioPharma and Lilly form drug discovery collaboration

Medarex and Raven Biotechnologies form antibody development collaboration

Meperidine analogues under study as dopamine uptake inhibitors by NIDA and collaborators

RHeoGene updates gene-switching development program at BIO 2000

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

ICAgen and Yamanouchi to develop novel CNS therapeutics

Genzyme Transgenics expands agreement with Centocor for second monoclonal antibody

Dyax and Human Genome Sciences enter drug discovery agreement

Millennium extends inflammation and autoimmune alliance with Kyowa Hakko

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS